GlassScriptPhysician profile
Melanie Thomas
NPI 1902538648
$1,950.33
in general payments reported to CMS, 2019-2025
15 companies · $69.45 in 2025
The $69.45 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2023: $1,507 · 2024: $234 · 2025: $69.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $991 · Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $991.38 |
| Food and Beverage | $818.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $589.16 | 2023 | |
| Prime Surgical, LLC | $523.22 | 2023 | |
| Djo, LLC | $183.30 | 2024 | Cmf |
| Curonix LLC | $130.70 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Astrazeneca Pharmaceuticals LP | $122.11 | 2023 | Andexxa |
| Heron Therapeutics, INC. | $122.11 | 2022 | |
| Baxter Healthcare | $85.81 | 2023 | |
| Ossur Americas, INC. | $48.18 | 2025 | |
| Si-Bone, INC. | $33.13 | 2023 | |
| Bioventus LLC | $31.98 | 2022-2024 | Bonescalpel & Sonicone (O.R.) |
| Vericel Corporation | $22.79 | 2023 | Maci |
| Solventum Corporation | $21.27 | 2025 | Prevena |
| Depuy Synthes Sales INC. | $17.25 | 2024 | Monovisc, Orthovisc |
| Smith+Nephew, INC. | $13.93 | 2024 | Oasis, Versajet |
| Heraeus Medical, LLC. | $5.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.